About
Vivifi Medical is developing ReFlow, a non-surgical, non-transurethral outpatient procedure in early clinical development designed to treat benign prostatic hyperplasia (BPH) by addressing its root cause, aiming to provide long-term symptom relief with minimal side effects.
Explore Vivifi Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.